Clinical Significance of Tumor-associated Antigen RCAS1 Expression in Human Pancreatic Ductal Adenocarcinoma
作者: Constantinos GiaginisDemetrios DavidesApostolos ZarrosOlga NoussiaAdamantia Zizi-SerbetzoglouGregorios KouraklisStamatios Theocharis
作者单位: 1Department of Forensic Medicine and Toxicology, Medical School, University of Athens
2Second Department of Propedeutic Surgery, Laikon Hospital, Medical School, University of Athens
3Department of Pathology, Tzaneio General Hospital
刊名: Digestive Diseases and Sciences, 2008, Vol.53 (6), pp.1728-1734
来源数据库: Springer Nature Journal
DOI: 10.1007/s10620-007-0035-7
关键词: Clinical significanceClinicopathological parametersImmunohistochemistryPancreatic adenocarcinomaPrognostic markerRCAS1 antigenSurvival
英文摘要: Abstract(#br)Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is a human tumor-associated antigen that induces cell cycle arrest and/or apoptosis in RCAS1 receptor-expressing immune cells. The aim of the present study was to evaluate the clinical significance of RCAS1 expression in human pancreatic adenocarcinoma. Immunohistochemical analysis of RCAS1 expression was performed on paraffin-embedded tissue sections obtained from 76 pancreatic adenocarcinoma patients. RCAS1 positivity and overexpression and intensity of the staining were correlated with clinicopathological parameters, proliferative capacity and patient survival. Of the 76 adenocarcinoma patients, 65 (86%) tested positive for RCAS1; of these 65 RCAS1-positive cases, 36 (55%) showed RCAS1 overexpression. RCAS1...
全文获取路径: Springer Nature  (合作)
影响因子:2.26 (2012)

  • associated 相关的